Locus Cell Co., Ltd. (TPEX:6891)
Taiwan · Delayed Price · Currency is TWD 53.10
-0.80 (-1.48%)
May 29, 2026, 1:55 PM CST
Locus Cell Market Cap
Locus Cell has a market cap or net worth of 10.6 billion as of May 29, 2026. Its market cap has increased by 145.43% in one year.
Market Cap
10.60B
Enterprise Value
10.15B
Revenue
12.74M
Ranking
n/a
PE Ratio
n/a
Stock Price
53.10
Market Cap Chart
Since April 28, 2022, Locus Cell's market cap has increased from 9.88B to 10.60B, an increase of 7.31%. That is a compound annual growth rate of 1.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 10.60B | 84.35% |
| Dec 31, 2025 | 5.75B | 44.14% |
| Dec 31, 2024 | 3.99B | -36.67% |
| Dec 29, 2023 | 6.30B | -12.86% |
| Dec 30, 2022 | 7.23B | -26.82% |
| Apr 28, 2022 | 9.88B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medigen Vaccine Biologics | 14.79B |
| CHO Pharma | 14.47B |
| TaiMed Biologics | 13.46B |
| EirGenix | 12.76B |
| Ever Supreme Bio Technology | 12.32B |
| Polaris Group | 12.21B |
| AP Biosciences | 10.74B |
| Tanvex BioPharma | 10.33B |